However, 5 years of follow-up indicated that within that period, after vagotomy, there is a reduced risk of PD, and very similar results were obtained in the 10-year follow-up
| Pernicious Anaemia So
However, like all medications, GLP-1 drugs carry risks
The scientific literature reveals that while copper-containing peptides can theoretically catalyze oxidation of susceptible amino acids in adjacent molecules, the actual risk depends entirely on substrate availability
Side Effects: What to Expect The most common side effects of GLP-1 medications are gastrointestinal symptoms, including nausea, vomiting, diarrhea, constipation, indigestion, and abdominal discomfort
The FDA approval timeline points to late 2027 at the earliest, with pharmacy availability likely in early 2028